MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, AXSM made $170,992,000 in revenue. -$47,229,000 in net income. Net profit margin of -27.62%.

Income Overview

Revenue
$170,992,000
Net Income
-$47,229,000
Net Profit Margin
-27.62%
EPS
-$0.94
Unit: Dollar
Revenue Breakdown
    • Product
    • Royalty
Revenue Breakdown
    • Auvelity-Product
    • Product-Sunosi
    • Royalty-Symbravo
    • Royalty-Sunosi
Revenue Breakdown
    • US
    • Non Us-Royalty
    • Non Us

Unit: Dollar
Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-12-31
Revenue
170,992,000 150,042,000 121,463,000 92,305,000
Cost of revenue (excluding amortization and depreciation)
11,912,000 13,448,000 9,789,000 8,288,666.667
Research and development
40,162,000 49,541,000 44,785,000 47,229,666.667
Selling, general and administrative
150,235,000 130,280,000 120,787,000 105,265,000
Loss in fair value of contingent consideration
13,185,000 -8,102,000 1,512,000 3,911,000
Intangible asset amortization
1,607,000 1,589,000 1,572,000 1,595,333.333
Total operating expenses
217,101,000 186,756,000 178,445,000 166,289,666.667
Loss from operations
-46,109,000 -36,714,000 -56,982,000 -72,646,000
Interest expense, net
-1,120,000 -1,834,000 -2,431,000 -1,530,333.333
Loss on debt extinguishment
--10,385,000 --
Loss before income taxes
-47,229,000 -48,933,000 -59,413,000 -74,176,333.333
Income tax benefit
--960,000 --
Income tax benefit
--960,000 -21,250
Net loss
-47,229,000 -47,973,000 -59,413,000 -74,204,666.667
Net loss per common share, basic
-0.94 -0.97 -1.22 -1.55
Net loss per common share, diluted
-0.94 -0.97 -1.22 -1.55
Weighted average common shares outstanding, basic
50,021,851 49,442,001 48,871,163 -75,422
Weighted average common shares outstanding, diluted
50,021,851 49,442,001 48,871,163 -75,422
Unit: Dollar

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$47,229,000 Loss before incometaxes-$47,229,000 Royalty$1,208,000 Product$169,784,000 Interest expense, net-$1,120,000 Loss from operations-$46,109,000 Revenue$170,992,000 Total operatingexpenses$217,101,000 Intangible assetamortization$1,607,000 Loss in fair value ofcontingent consideration$13,185,000 Selling, general andadministrative$150,235,000 Research and development$40,162,000 Cost of revenue(excluding amortization...$11,912,000

Axsome Therapeutics, Inc. (AXSM)

Axsome Therapeutics, Inc. (AXSM)